Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sergio Traversa Insider Profile
4 Followers
Sergio Traversa, Director at Actinium Pharmaceuticals, holds 75.49K shares in Relmada Therapeutics (Ticker: RLMD), holds 0.00 shares in Actinium Pharmaceuticals (Ticker: ATNM).
Sergio Traversa has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sergio Traversa holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Apr 18, 2016 - Apr 18, 2017
Return:-22.60%
The most profitable trade made by Sergio Traversa
Sergio Traversa's Trading History
Actinium Pharmaceuticals
Apr 18, 2016
Director
Informative Buy
6.06K
$0.00
Relmada Therapeutics
Aug 19, 2020
CEO, Director
Uninformative Sell
162.01K
$2.72M
List of latest transactions for each holding click on a transaction to see Sergio Traversa's performance on stock
You May Also Like
Sergio Traversa insider profile FAQ
What is the percentage of profitable transactions made by Sergio Traversa?
The percentage of profitable transactions made by Sergio Traversa is ―.
What is the average return per transaction made by Sergio Traversa?
The average return per transaction made by Sergio Traversa is ―.
What stocks does Sergio Traversa hold?
Sergio Traversa holds: ATNM, RLMD stocks.
What was Sergio Traversa’s latest transaction?
Sergio Traversa latest transaction was an Uninformative Sell of $162.01K.
What was Sergio Traversa's most profitable transaction?
Sergio Traversa’s most profitable transaction was an Informative Buy of ATNM stock on April 18, 2016. The return on the trade was -22.60%.
What is Sergio Traversa's role in Actinium Pharmaceuticals?
Sergio Traversa's role in Actinium Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.